Editorial
Los biosimilares, una nueva era en la reumatología en España
Biosimilars, a new era in rheumatology in Spain
Leído
6465
Vecesse ha leído el artículo
2328
Total PDF
4137
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 8 | 4 | 12 |
| 2025 5 | 156 | 41 | 197 |
| 2025 4 | 141 | 32 | 173 |
| 2025 3 | 132 | 28 | 160 |
| 2025 2 | 119 | 34 | 153 |
| 2025 1 | 126 | 30 | 156 |
| 2024 12 | 86 | 35 | 121 |
| 2024 11 | 112 | 63 | 175 |
| 2024 10 | 106 | 31 | 137 |
| 2024 9 | 116 | 19 | 135 |
| 2024 8 | 96 | 46 | 142 |
| 2024 7 | 88 | 31 | 119 |
| 2024 6 | 81 | 28 | 109 |
| 2024 5 | 72 | 23 | 95 |
| 2024 4 | 85 | 25 | 110 |
| 2024 3 | 57 | 32 | 89 |
| 2024 2 | 74 | 29 | 103 |
| 2024 1 | 68 | 32 | 100 |
| 2023 12 | 62 | 34 | 96 |
| 2023 11 | 69 | 61 | 130 |
| 2023 10 | 97 | 46 | 143 |
| 2023 9 | 103 | 33 | 136 |
| 2023 8 | 58 | 14 | 72 |
| 2023 7 | 56 | 31 | 87 |
| 2023 6 | 60 | 33 | 93 |
| 2023 5 | 49 | 31 | 80 |
| 2023 4 | 45 | 17 | 62 |
| 2023 3 | 75 | 21 | 96 |
| 2023 2 | 66 | 24 | 90 |
| 2022 1 | 44 | 18 | 62 |
| 2022 12 | 74 | 31 | 105 |
| 2022 11 | 91 | 30 | 121 |
| 2022 10 | 82 | 39 | 121 |
| 2022 9 | 44 | 41 | 85 |
| 2022 8 | 68 | 42 | 110 |
| 2022 7 | 78 | 41 | 119 |
| 2022 6 | 39 | 36 | 75 |
| 2022 5 | 46 | 55 | 101 |
| 2022 4 | 30 | 38 | 68 |
| 2022 3 | 35 | 45 | 80 |
| 2022 2 | 42 | 51 | 93 |
| 2021 1 | 43 | 65 | 108 |
| 2021 12 | 43 | 75 | 118 |
| 2021 11 | 47 | 57 | 104 |
| 2021 10 | 40 | 60 | 100 |
| 2021 9 | 35 | 48 | 83 |
| 2021 8 | 39 | 59 | 98 |
| 2021 7 | 45 | 39 | 84 |
| 2021 6 | 51 | 47 | 98 |
| 2021 5 | 61 | 56 | 117 |
| 2021 4 | 125 | 145 | 270 |
| 2021 3 | 92 | 70 | 162 |
| 2021 2 | 52 | 24 | 76 |
| 2020 1 | 54 | 28 | 82 |
| 2020 12 | 40 | 22 | 62 |
| 2020 11 | 79 | 42 | 121 |
| 2020 10 | 31 | 31 | 62 |
| 2020 9 | 48 | 42 | 90 |
| 2020 8 | 1 | 1 | 2 |
| 2020 7 | 8 | 4 | 12 |
| 2020 6 | 13 | 16 | 29 |
| 2020 5 | 49 | 13 | 62 |
| 2020 4 | 1 | 0 | 1 |
| 2020 3 | 1 | 2 | 3 |
| 2020 2 | 3 | 7 | 10 |
Mostrar todo
